期刊文献+

血管内皮细胞生长因子表达肿瘤微血管密度的意义 被引量:1

Significance of expression MVD by means of VEGF
下载PDF
导出
摘要 目的应用小鼠肿瘤模型,通过血管内皮细胞生长因子表达肿瘤微血管密度,了解血管抑素抑制肿瘤血管新生。方法免疫组化测定血管内皮细胞生长因子,通过肿瘤微血管密度表达肿瘤血管生长的情况,探讨肿瘤血管新生发生的可能机制。结果血管内皮细胞生长因子在肿瘤中的表达较少,主要表达在内皮细胞中。结论血管内皮细胞生长因子可以表达肿瘤血管密度,证明血管抑素可以抑制肿瘤血管新生。 Objective Applicating for the mice tumor model, we has examined VEGF for expressing MVD. Methods The VEGFdetermined by immunohistochemistry express MVD to explore mechanism in the course of anti-angiogenesis. Results VEGF expression is higher in endothelial cell than in tumor. Conclusion VEGF can express MVD in tumor. Our findings indicate that AS may play an important role in prohibite angiogenesis.
出处 《中国实验诊断学》 2006年第6期596-598,共3页 Chinese Journal of Laboratory Diagnosis
基金 吉林省科委科研基金资助(990564)
关键词 血管抑素 血管内皮细胞生长因子 微血管密度 angiostatin VEGF MVD(Microvessel density)
  • 相关文献

参考文献5

  • 1Nor JE,Christensen J,Mooney DJ,et al.Vascular endothelial growth factor(VEGF)-mediated angiogenesis is associated with ennanced endothelial cell survival and induction of Bcl-2 expression[J].Am J Pathol,1999,154:375.
  • 2铃木磨郎.肿疡循环特性に基づいた制癌剂の组织浓度と滞留时间の选择的增加に关する研究[J].ガんのあゆみ,1987,7(3):77.
  • 3Weidner N.Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors[J].Breast Cancer Res Treat,1995,36:169.
  • 4吴扬兰,王远亮.肿瘤新生血管抑制剂——血管抑素和内皮抑素[J].重庆大学学报(自然科学版),2003,26(10):72-75. 被引量:6
  • 5孙立新,武燕,连润生,韩海琼,王全红,焦士兰.血管内皮生长因子、p53在卵巢上皮癌中表达的临床意义[J].肿瘤研究与临床,2004,16(5):306-308. 被引量:7

二级参考文献29

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2FOLKMAN M J, COTRAN R S. Relation of vascular proliferation to tumor growth[J]. Int Rev Exp Pathol, 1976,16:207- 215.
  • 3FOLKMAN M J. Fighting cancer by attacking its bloods supply[J]. Sci Am 1996,2 75:150 - 154.
  • 4O REILLY MS, BOCHM T, SHING Y, et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth [ J ].Cell, 1997, 88 : 277 -285.
  • 5PARANGIS, OREILLY M, CHRISTOFORI. G, et al. Antiangiogenic therapy of transgenic mice impairs denovotumor growth[J]. Proc Nalt Acad Sci USA, 1996, 93(5) : 2 002 -2007.
  • 60 REILLY MS, HOLMAGREN L, SHING Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediate the suppression of metastases by a lewis lung carcinoma [ J ].cell, 1994, 79:315 -328.
  • 7LUCAS R, HOLMGREN L, GARCIAL, et al. Multiple forms of engiestatin induces apoptesis in endothelial cells[J]. Blood, 1998, 92:4 730-4 741.
  • 8REDUTZ A, DAUM G, SAGE E H. Angiostatin diminishes activation of the mitogcn - activated protein kineses ERK - 1and ERK - 2 in human dermal microvascular endothelial[J]. cells,J Vasc Res. 1999,36:28 -34.
  • 9O REILLY M S, FOLKMAN M.I. Therapeutic antiangiogenic compositions and methods. US5854, 205. ,1998- 12-29.
  • 10CAO Y, O REILLY MS, MARSHALL BETAL. Expression of angiestatin cDNA in a murine fibresareoma suppresses primary tumor growth and produces long - term dormancy of metastases[ J ]. J Clin Invest, 1998,101 (5) : 1 055 - 1 063.

共引文献11

同被引文献29

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部